Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Denies P&G Petition For OTC Proton Pump Inhibitor Class Labeling

This article was originally published in The Tan Sheet

Executive Summary

FDA's rejection of a Procter & Gamble citizen petition seeking class labeling for OTC proton pump inhibitors clears a roadblock for Schering-Plough's Zegerid to potentially make an "immediate release" claim

You may also be interested in...



Pharma Firms Stir OTC Market, FDA Hones Enforcement: Top Stories Of 2009

Firms entering or expanding their presence in the OTC drug and nutritional product markets as part of pharmaceutical industry shuffling in 2009 attracted the attention of stakeholders already competing in those markets

Pharma Firms Stir OTC Market, FDA Hones Enforcement: Top Stories Of 2009

Firms entering or expanding their presence in the OTC drug and nutritional product markets as part of pharmaceutical industry shuffling in 2009 attracted the attention of stakeholders already competing in those markets

Pharma Firms Stir OTC Market, FDA Hones Enforcement: Top Stories Of 2009

Firms entering or expanding their presence in the OTC drug and nutritional product markets as part of pharmaceutical industry shuffling in 2009 attracted the attention of stakeholders already competing in those markets

Related Content

Topics

UsernamePublicRestriction

Register

PS103452

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel